Azabenzofuran substituted thioureas as inhibitors of viral replication

Details for Australian Patent Application No. 2005204369 (hide)

Owner Achillion Pharmaceuticals, Inc.

Inventors Li, Shouming; Chen, Dawei; Phadke, Avinash; Deshpande, Milind; Thurkauf, Andrew

Agent Cullens

Pub. Number AU-B-2005204369

PCT Pub. Number WO2005/067900

Priority 60/534,839 06.01.04 US

Filing date 5 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 10 June 2010

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/00 (2006.01)

A61K 31/4355 (2006.01)

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/067900 Priority application(s): WO2005/067900

10 June 2010 Application Accepted

  Published as AU-B-2005204369

7 October 2010 Standard Patent Sealed

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204372-Child resistant visible blister end cap

2005204368-Ormosil aerogels containing silicon bonded linear polymers